Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines

The discovery of cancer cell-selective tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis generated broad excitement and development of TRAIL receptor agonists (TRA) as potential cancer therapy. Studies demonstrating the synergistic combination effect of SMAC mimetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Polanski, R, Vincent, J, Polanska, U M, Petreus, T, Tang, E K Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632282/
https://www.ncbi.nlm.nih.gov/pubmed/26426685
http://dx.doi.org/10.1038/cddis.2015.234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632282/
https://www.ncbi.nlm.nih.gov/pubmed/26426685
http://dx.doi.org/10.1038/cddis.2015.234

Ejemplares similares